Mission Statement:

To improve the care and outcomes of kidney disease
patients worldwide through promoting coordination,
collaboration and integration of initiatives to develop
and implement clinical practice guidelines.

 

Abbreviations and acronyms

AASLD American Association for the Study HIV Human immunodeficiency virus
of LiverDisease INR International normalized ratio
ACEI Angiotensin-converting enzyme inhibitor(s) IVDU Intravenous drug user
ADA American Diabetes Association KDIGO Kidney Disease: Improving Global Outcomes
ALT Alanine aminotransferase KDOQI Kidney Disease Outcomes Quality Initiative
ARB Angiotensin receptor blocker(s) MGN Membranous glomerulonephritis
AST Aspartate aminotransferase MPGN Membranoproliferative
AUC Area under the curve NAT Nucleic acid test(ing)
CARI Caring for Australians with Renal Impairment NHANES III Third National Health and Nutrition Survey
CDC Centers for Disease Control and Prevention NIH National Institutes of Health
CKD Chronic kidney disease NODAT New-onset diabetes after transplantation
CSN Canadian Society of Nephrology PCR Polymerase chain reaction
DOPPS Dialysis Outcomes and Practice Patterns Study RCT Randomized controlled trial
EBPG European Best Practice Guidelines ROC Receiver operating characteristics
EDTA Ethylenediaminetetraacetic acid RR Relative risk
EIA Enzyme immunoassay SVR Sustained virologic response
GFR Glomerular filtration rate SQ Subcutaneous(ly)
GN Glomerulonephritis TLR-3 TOLL-like receptor 3
GRADE Grades of Recommendation, Assessment, TMA Transcription-mediated amplification
Development and Evaluation UK-RA United Kingdom Renal Association
HBV Hepatitis B virus USRDS United States Renal Data System
HCV Hepatitis C virus WHO World Health Organization

Reference Keys